Carl Gordon

Carl Gordon

Vermogen: 58 170 $ op 31-08-2026

61 jaar
Health Technology
Finance
Commercial Services

Profiel

Dr. Carl L.
Gordon is an Independent Director at Electra Therapeutics, Inc., a Chairman at Compass Therapeutics, Inc., a Managing Partner at OrbiMed Advisors Private Equity, a Managing Partner at OrbiMed Advisors LLC, an Advisor at The New York City Investment Fund Manager, Inc., an Independent Director at Avenzo Therapeutics, Inc. /New/ and a Principal at Aragon Pharmaceuticals, Inc. He is on the Board of Directors at Lomond Therapeutics Holdings, Inc., Scribe Therapeutics, Inc., Blossomhill Therapeutics, Inc., ADARx Pharmaceuticals, Inc., Electra Therapeutics, Inc., Adimab LLC, Agensys, Inc., Amnis Corp., Emendo Biotherapeutics, Inc., Frontera Therapeutics (HK) Ltd., Gemini Therapeutics Sub, Inc., Gwynant Therapeutics, Inc., Kumquat Biosciences, Inc., Sapphire Therapeutics, Inc., Star OpCo, Inc., Stratus Therapeutics, Inc., X4 Pharmaceuticals (Austria) GmbH, XinThera, Inc. and Avenzo Therapeutics, Inc. /New/.
Dr. Gordon was previously employed as an Independent Director by Arrivent BioPharma, Inc., an Independent Director by MBX Biosciences, Inc., an Independent Director by Keros Therapeutics, Inc., an Independent Director by Kinnate Biopharma, Inc., an Independent Director by Terns Pharmaceuticals, Inc., an Independent Non-Executive Director by Passage Bio, Inc., an Independent Director by Theseus Pharmaceuticals, Inc., an Independent Director by Springworks Therapeutics, Inc., a Lead Independent Director by Turning Point Therapeutics, Inc., an Independent Director by Gemini Therapeutics, Inc., an Independent Director by Oric Pharmaceuticals, Inc., a Chairman by Adicet Bio, Inc., an Independent Director by Intellia Therapeutics, Inc., an Independent Director by Alector, Inc., an Independent Director by Arsanis, Inc., an Independent Director by Selecta Biosciences, Inc., an Independent Director by Complete Genomics, Inc., an Independent Non-Executive Director by Amarin Corp.
Plc, and an Independent Director by Pacira Pharmaceuticals, Inc.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
04-06-2025 5.250 ( 0,03% ) 58 170 $ 31-08-2026
31-03-2026 0 ( -.--% ) - $ 31-08-2026
06-08-2026 0 ( -.--% ) - $ 31-08-2026

Actieve functies van Carl Gordon

BedrijvenFunctieBegin
COMPASS THERAPEUTICS, INC. Voorzitter 01-01-2015
BLOSSOMHILL THERAPEUTICS, INC. Directeur/Bestuurslid 01-02-2021
ELECTRA THERAPEUTICS, INC. Directeur/Bestuurslid 01-03-2019
SCRIBE THERAPEUTICS INC. Directeur/Bestuurslid 01-03-2021
Oprichter 01-01-1989
X4 Pharmaceuticals (Austria) GmbH
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ -
░░░ ░░░ ░░░░ ░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░ ░ ░░░░░░░░ -

Eerdere bekende functies van Carl Gordon

BedrijvenFunctieEinde
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Carl Gordon in detail bekijken

Opleiding van Carl Gordon

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

62

Eerstegraads connecties

62

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit62

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Finance

Finance

Finance

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

X4 Pharmaceuticals (Austria) GmbH

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Carl Gordon
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU